Effect of Dapagliflozin on the Blood Pressure Variability and the Ambulatory Arterial Stiffness Index in Individuals With Stage I Hypertension Without Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2019
Price : $35 *
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 05 Jul 2019 Planned End Date changed from 1 May 2019 to 1 Nov 2019.
- 05 Jul 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Nov 2019.
- 26 Jul 2018 New trial record